Tech Company Financing Transactions
Bota Biosciences Funding Round
Sequoia Capital, Matrix Partners and Morningside Group participated in a $100 million Series B funding round for Bota Biosciences. This VC investment round was announced on 8/2/2021.
Transaction Overview
Company Name
Announced On
8/2/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
Sequoia Capital (Lead Investor) (Neil Shen)
Proceeds Purpose
The new funds will be used to expand the company's global operations and build out Bota Bio's lab-to-pilot scale platform to facilitate the rapid scale-up and deployment of the company's product pipeline in consumer goods, food, nutrition, and pharmaceutical products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3515 Mt Diablo Blvd.
Lafayette, CA 94549
USA
Lafayette, CA 94549
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Bota Bio is a global industrial biotechnology company focused on programming biological systems for the clean and efficient biomanufacturing of common household and industrial products. Bota Bio is led by an experienced, multidisciplinary team of industry veterans combining data and automation to translate biotechnologies into business value and consumer welfare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cheryl Cui
Browse more venture capital transactions:
Prev: 8/2/2021: OOVA venture capital transaction
Next: 8/2/2021: Rakuten Medical venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs